DSpace Repository

BTK inhibitors as potential therapies for multiple sclerosis

Show simple item record

dc.contributor.author Correale, Jorge
dc.date.accessioned 2021-09-15T17:00:14Z
dc.date.available 2021-09-15T17:00:14Z
dc.date.issued 2021-08-19
dc.identifier.citation Correale J. BTK inhibitors as potential therapies for multiple sclerosis. Lancet Neurol. 2021 Sep;20(9):689-691. doi: 10.1016/S1474-4422(21)00250-7 es_ES
dc.identifier.uri https://doi.org/10.1016/S1474-4422(21)00250-7
dc.identifier.uri https://repositorio.fleni.org.ar/xmlui/handle/123456789/586
dc.description.abstract Resumen no disponible es_ES
dc.language.iso eng es_ES
dc.publisher Elsevier es_ES
dc.rights info:eu-repo/semantics/openAccess
dc.rights.uri https://creativecommons.org/licenses/by/2.5/ar/
dc.subject Multiple Sclerosis es_ES
dc.subject Esclerosis Múltiple es_ES
dc.subject Protein Kinase Inhibitors es_ES
dc.subject Inhibidores de Proteínas Quinasas es_ES
dc.title BTK inhibitors as potential therapies for multiple sclerosis es_ES
dc.type info:eu-repo/semantics/article es_ES
dc.type info:eu-repo/semantics/publishedVersion
dc.description.fil Fil: Correale, Jorge. Fleni. Departamento de Neurología. Servicio de Neuroinmunología y Enfermedades Desmielinizantes; Argentina.
dc.relation.ispartofVOLUME 20
dc.relation.ispartofNUMBER 9
dc.relation.ispartofPAGINATION 689-691
dc.relation.ispartofCOUNTRY Reino Unido
dc.relation.ispartofCITY Londres
dc.relation.ispartofTITLE The Lancet. Neurology
dc.relation.ispartofISSN 1474-4465
dc.type.snrd info:ar-repo/semantics/artículo es_ES


Files in this item

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/openAccess Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess

Search DSpace


Browse

My Account

Statistics